# GeneDx Holdings Corp.: insider transactions

WGS · Nasdaq · CIK 1818331 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wgs.md) · [Financials](/companies/wgs/financials.md) · [Filings](/companies/wgs/filings.md) · [Insiders](/companies/wgs/insiders.md)

## All transactions: 3

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2022-04-29 | [Blackstone Tactical Opportunities Associates III - NQ L.P.](/insiders/1826419.md) | 10% owner | Purchase (P) | 14,735 | $4.00 | $58.9k | [Form 4](/filings/0000899243-22-016476.md) |
| 2022-04-29 | [Blackstone Tactical Opportunities Associates III - NQ L.P.](/insiders/1826419.md) | 10% owner | Purchase (P) | 50,402 | $4.00 | $201.6k | [Form 4](/filings/0000899243-22-016476.md) |
| 2022-04-29 | [Blackstone Tactical Opportunities Associates III - NQ L.P.](/insiders/1826419.md) | 10% owner | Purchase (P) | 2,434,863 | $4.00 | $9.7m | [Form 4](/filings/0000899243-22-016476.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.